Researchers will run samples collected by brushing lesions through an automated system to detect abnormal DNA content and malignant changes. By identifying high-risk lesions, closer follow-up and early intervention can be used to prevent malignancies. The goal is to establish a centralized lab at BC Cancer to process samples to identify the risk of malignant transformation for FA patients.
Researchers: Martial Guillaud, Denise LaRonde